Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lena Carlsson

Showing results (61-70 of 64) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 64 results.
Renal Failure|May 30, 2013
A fixed protocol for outpatient clinic routines in the care of patients with severe renal failureHenrik Hadimeri, Carsten Frisenette-Fich, Sven-Ingemar Deurell, et al.
JAMA|November 9, 2016
Effect of Tailored Dose-Dense Chemotherapy vs Standard 3-Weekly Adjuvant Chemotherapy on Recurrence-Free Survival Among Women With High-Risk Early Breast Cancer: A Randomized Clinical TrialTheodoros Foukakis, Gunter von Minckwitz, Nils-Olof Bengtsson, et al.
JAMA Oncology|June 24, 2021
Neoadjuvant Trastuzumab, Pertuzumab, and Docetaxel vs Trastuzumab Emtansine in Patients With ERBB2-Positive Breast Cancer: A Phase 2 Randomized Clinical TrialThomas Hatschek, Theodoros Foukakis, Judith Bjöhle, et al.
The Lancet. Digital Health|August 31, 2023
Development and validation of an interpretable machine learning-based calculator for predicting 5-year weight trajectories after bariatric surgery: a multinational retrospective cohort SOPHIA studyPatrick Saux, Pierre Bauvin, Violeta Raverdy, et al.
Pageof 7

Showing results (61-70 of 64) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 64 results.
Renal Failure|May 30, 2013
A fixed protocol for outpatient clinic routines in the care of patients with severe renal failureHenrik Hadimeri, Carsten Frisenette-Fich, Sven-Ingemar Deurell, et al.
JAMA|November 9, 2016
Effect of Tailored Dose-Dense Chemotherapy vs Standard 3-Weekly Adjuvant Chemotherapy on Recurrence-Free Survival Among Women With High-Risk Early Breast Cancer: A Randomized Clinical TrialTheodoros Foukakis, Gunter von Minckwitz, Nils-Olof Bengtsson, et al.
JAMA Oncology|June 24, 2021
Neoadjuvant Trastuzumab, Pertuzumab, and Docetaxel vs Trastuzumab Emtansine in Patients With ERBB2-Positive Breast Cancer: A Phase 2 Randomized Clinical TrialThomas Hatschek, Theodoros Foukakis, Judith Bjöhle, et al.
The Lancet. Digital Health|August 31, 2023
Development and validation of an interpretable machine learning-based calculator for predicting 5-year weight trajectories after bariatric surgery: a multinational retrospective cohort SOPHIA studyPatrick Saux, Pierre Bauvin, Violeta Raverdy, et al.
Pageof 7